LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 144

Search options

  1. Article: Quand penser a la BPCO et comment I'evaluer?

    Tillie-Leblond, Isabelle

    La Revue du praticien

    2011  Volume 61, Issue 6, Page(s) 789–793

    Abstract: Detected in 30% of COPD patients and underdiagnosed, COPD must be systematically investigated in all about 40 years-old smokers, without waiting for clinical symptoms, late and inconstant. The diagnosis is made with spirometry. Search for a status of " ... ...

    Title translation When to consider COPD and how to assess it?.
    Abstract Detected in 30% of COPD patients and underdiagnosed, COPD must be systematically investigated in all about 40 years-old smokers, without waiting for clinical symptoms, late and inconstant. The diagnosis is made with spirometry. Search for a status of "frequent exacerbations", co-morbidities (including cardio-vascular disease), evaluation of dyspnea intensity with a scale (MRC), assessment of disease impact on daily life, allow to identify risk groups and to target the therapeutic management overall. Pulmonary rehabilitation, in addition to medication, improves dyspnea, and decreases the impact of COPD on daily life.
    MeSH term(s) Humans ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Surveys and Questionnaires
    Language French
    Publishing date 2011-06
    Publishing country France
    Document type English Abstract ; Journal Article
    ZDB-ID 205365-2
    ISSN 2101-017X ; 0035-2640
    ISSN (online) 2101-017X
    ISSN 0035-2640
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: La bronchopneumopathie chronique obstructive : débats.

    Tillie-Leblond, I / Housset, B

    Revue des maladies respiratoires

    2010  Volume 27, Issue 2, Page(s) 106–107

    Title translation Debates surrounding COPD.
    MeSH term(s) Administration, Inhalation ; Adrenal Cortex Hormones/adverse effects ; Adrenal Cortex Hormones/therapeutic use ; Albuterol/adverse effects ; Albuterol/analogs & derivatives ; Albuterol/therapeutic use ; Androstadienes/adverse effects ; Androstadienes/therapeutic use ; Anti-Inflammatory Agents/adverse effects ; Anti-Inflammatory Agents/therapeutic use ; Breathing Exercises ; Bronchodilator Agents/adverse effects ; Bronchodilator Agents/therapeutic use ; Combined Modality Therapy ; Drug Therapy, Combination ; Fluticasone ; Humans ; Oxygen Inhalation Therapy ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Pulmonary Disease, Chronic Obstructive/mortality ; Randomized Controlled Trials as Topic ; Salmeterol Xinafoate ; Scopolamine Derivatives/adverse effects ; Scopolamine Derivatives/therapeutic use ; Smoking Cessation ; Tiotropium Bromide
    Chemical Substances Adrenal Cortex Hormones ; Androstadienes ; Anti-Inflammatory Agents ; Bronchodilator Agents ; Scopolamine Derivatives ; Salmeterol Xinafoate (6EW8Q962A5) ; Fluticasone (CUT2W21N7U) ; Albuterol (QF8SVZ843E) ; Tiotropium Bromide (XX112XZP0J)
    Language French
    Publishing date 2010-02
    Publishing country France
    Document type Comment ; Comparative Study ; Editorial
    ZDB-ID 605743-3
    ISSN 1776-2588 ; 0301-0279 ; 0761-8425
    ISSN (online) 1776-2588
    ISSN 0301-0279 ; 0761-8425
    DOI 10.1016/j.rmr.2010.01.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Pneumopathies infiltrantes diffuses (PID).

    Tillie-Leblond, I

    Revue des maladies respiratoires

    2006  Volume 23, Issue 1 Pt 2, Page(s) 2S49–51

    Title translation Diffuse infiltrative lung diseases.
    MeSH term(s) Antigens, Neoplasm/blood ; Biomarkers ; Hexosaminidases/blood ; Humans ; Hypertension, Pulmonary/physiopathology ; Lung Diseases, Interstitial/blood ; Lung Diseases, Interstitial/drug therapy ; Lung Diseases, Interstitial/physiopathology ; Mucin-1 ; Mucins/blood
    Chemical Substances Antigens, Neoplasm ; Biomarkers ; MUC1 protein, human ; Mucin-1 ; Mucins ; Hexosaminidases (EC 3.2.1.-) ; chitotriosidase (EC 3.2.1.-)
    Language French
    Publishing date 2006-02
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 605743-3
    ISSN 0761-8425 ; 0301-0279
    ISSN 0761-8425 ; 0301-0279
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Asthme.

    Tillie-Leblond, I

    Revue des maladies respiratoires

    2006  Volume 23, Issue 1 Pt 2, Page(s) 2S36–8

    Title translation Asthma.
    MeSH term(s) Animals ; Asthma/diagnosis ; Asthma/etiology ; Asthma/physiopathology ; Humans ; Muscle, Smooth/physiopathology ; Risk Factors ; Smoking/adverse effects
    Language French
    Publishing date 2006-02
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 605743-3
    ISSN 0761-8425 ; 0301-0279
    ISSN 0761-8425 ; 0301-0279
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Comment améliorer le contrôle de l'asthme ?

    Roche, Nicolas / Tillie-Leblond, Isabelle

    Presse medicale (Paris, France : 1983)

    2009  Volume 38, Issue 10, Page(s) 1495–1505

    Abstract: Asthma control is the cornerstone of monitoring for patients with this disease. Monitoring limited to questions of the type "how is your asthma?" underestimates the real effects of the disease. Measuring control requires assessing several criteria, which ...

    Title translation Improving the control of asthma.
    Abstract Asthma control is the cornerstone of monitoring for patients with this disease. Monitoring limited to questions of the type "how is your asthma?" underestimates the real effects of the disease. Measuring control requires assessing several criteria, which differ by the kinetics of their course during treatment. Basing monitoring on only a single criterion risks overestimating control, stepping down treatment too early, and losing control of the disease. In the case of inadequate control, uncontrolled comorbid conditions and aggravating factors or poor treatment adhesion must be sought before determining that the treatment itself is insufficient. After stepping up treatment, the chances of obtaining adequate control increase progressively with time, for at least a year. When the physician and patient jointly determine that the current treatment is the maximum acceptable, waiting may be a solution. Similarly, in seeking the minimal efficacious treatment, treatment must not be stepped down too rapidly. Once control is obtained, continuation of the treatment maintains long-term control for most patients.
    MeSH term(s) Anti-Asthmatic Agents/administration & dosage ; Anti-Asthmatic Agents/adverse effects ; Anti-Asthmatic Agents/therapeutic use ; Asthma/drug therapy ; Asthma/physiopathology ; Chronic Disease ; Comorbidity ; Humans ; Maximal Expiratory Flow Rate ; Patient Compliance ; Patient Participation ; Recurrence ; Risk Factors ; Severity of Illness Index
    Chemical Substances Anti-Asthmatic Agents
    Language French
    Publishing date 2009-10
    Publishing country France
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 120943-7
    ISSN 2213-0276 ; 0032-7867 ; 0755-4982 ; 0301-1518
    ISSN (online) 2213-0276
    ISSN 0032-7867 ; 0755-4982 ; 0301-1518
    DOI 10.1016/j.lpm.2008.12.030
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Atteintes respiratoires des myopathies inflammatoires.

    Tillie-Leblond, I / Cadranel, J

    Revue des maladies respiratoires

    2007  Volume 23, Issue 6, Page(s) 764–766

    Title translation Respiratory injuries of inflammatory myopathies.
    MeSH term(s) Adrenal Cortex Hormones/therapeutic use ; Drug Therapy, Combination ; Humans ; Immunosuppressive Agents/therapeutic use ; Lung Diseases, Interstitial/etiology ; Myositis/complications ; Myositis/diagnosis ; Myositis/drug therapy ; Pneumonia/diagnosis ; Pneumonia/drug therapy ; Pneumonia/etiology ; Pneumonia, Aspiration/etiology ; Risk Factors ; Treatment Outcome
    Chemical Substances Adrenal Cortex Hormones ; Immunosuppressive Agents
    Language French
    Publishing date 2007-08-29
    Publishing country France
    Document type Journal Article
    ZDB-ID 605743-3
    ISSN 0761-8425 ; 0301-0279
    ISSN 0761-8425 ; 0301-0279
    DOI 10.1016/s0761-8425(06)72094-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Conférence d'experts SPLF 2007 Asthme et Allergie.

    Tillie-Leblond, I / Godard, P

    Revue des maladies respiratoires

    2007  Volume 24, Issue 8 Pt 3, Page(s) 7S3–4

    Title translation The Francophone Society of Pneumology Expert Conference on Asthma and Allergy, 2007.
    MeSH term(s) Asthma/therapy ; Humans ; Hypersensitivity/therapy ; Practice Guidelines as Topic ; Pulmonary Medicine
    Language French
    Publishing date 2007-10
    Publishing country France
    Document type Editorial ; Introductory Journal Article
    ZDB-ID 605743-3
    ISSN 0761-8425 ; 0301-0279
    ISSN 0761-8425 ; 0301-0279
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Exacerbations de l'asthme chez la femme enceinte.

    Prudhomme, A / Frys, S / Tillie-Leblond, I

    Revue des maladies respiratoires

    2011  Volume 28, Issue 6, Page(s) 834–838

    Abstract: Prevention of exacerbations and effective treatment is essential in pregnant asthmatic women. The management is well documented. Misunderstanding of the recommendations leads to unsuitable, insufficient treatment and is responsible for more frequent ... ...

    Title translation Exacerbations of asthma in pregnant women.
    Abstract Prevention of exacerbations and effective treatment is essential in pregnant asthmatic women. The management is well documented. Misunderstanding of the recommendations leads to unsuitable, insufficient treatment and is responsible for more frequent recurrences in the pregnant woman compared with the non pregnant. Above all, good control of the disease and the prevention of exacerbations, based on inhaled corticosteroid therapy and smoking cessation, reduces complications, in particular prematurity and low birth weight.
    MeSH term(s) Anti-Asthmatic Agents/adverse effects ; Anti-Asthmatic Agents/pharmacology ; Anti-Asthmatic Agents/therapeutic use ; Asthma/drug therapy ; Asthma/physiopathology ; Asthma/therapy ; Cohort Studies ; Dyspnea/etiology ; Dyspnea/prevention & control ; Female ; Fetus/drug effects ; Humans ; Infant, Newborn ; Meta-Analysis as Topic ; Obesity/complications ; Obstetric Labor, Premature/prevention & control ; Oxygen Inhalation Therapy ; Pregnancy ; Pregnancy Complications/drug therapy ; Pregnancy Complications/physiopathology ; Pregnancy Complications/prevention & control ; Pregnancy Complications/therapy ; Recurrence ; Risk Factors ; Smoking Cessation
    Chemical Substances Anti-Asthmatic Agents
    Language French
    Publishing date 2011-06
    Publishing country France
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 605743-3
    ISSN 1776-2588 ; 0301-0279 ; 0761-8425
    ISSN (online) 1776-2588
    ISSN 0301-0279 ; 0761-8425
    DOI 10.1016/j.rmr.2010.12.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: "EXACO": suivi sur 4 ans des exacerbations d'une cohorte de patients atteints de bronchopneumopathie chronique obstructive.

    Tillie-Leblond, I / Masure, F

    Revue des maladies respiratoires

    2006  Volume 23, Issue 4 Pt 1, Page(s) 377–384

    Abstract: EXACO is a French prospective observational epidemiological study. Chest physicians will enrol 1200 patients who will be followed up for 4 years. The aims of the study are to describe the exacerbations in COPD patients at different levels of severity and ...

    Title translation "EXACO": four year follow-up of exacerbations in a cohort of patients with COPD.
    Abstract EXACO is a French prospective observational epidemiological study. Chest physicians will enrol 1200 patients who will be followed up for 4 years. The aims of the study are to describe the exacerbations in COPD patients at different levels of severity and to confirm the existence of a sub-group of patients defined as frequent exacerbators. The clinical characteristics associated with this profile and the decline of FEV1 will be evaluated. A validation of the VSRQ scale will be performed. The data will be collected from chest physicians and by phone calls to the patients every three months.
    MeSH term(s) Algorithms ; Cohort Studies ; Forced Expiratory Volume ; France/epidemiology ; Humans ; Peak Expiratory Flow Rate ; Prospective Studies ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/epidemiology ; Pulmonary Disease, Chronic Obstructive/physiopathology ; Respiratory Function Tests ; Severity of Illness Index
    Language French
    Publishing date 2006-10-15
    Publishing country France
    Document type English Abstract ; Journal Article
    ZDB-ID 605743-3
    ISSN 0761-8425 ; 0301-0279
    ISSN 0761-8425 ; 0301-0279
    DOI 10.1016/s0761-8425(06)71607-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Introduction pour le texte court de la conférence d'experts de la Société de Pneumologie de Langue Française en partenariat avec la SFAIC, la SFMT et l'association "Asthme - Allergie" sur asthme et allergie.

    Tillie-Leblond, I / Godard, P

    Revue des maladies respiratoires

    2006  Volume 24, Issue 2, Page(s) 221–222

    Title translation Introduction for short texts from "La conférence d'experts de la Société de Pneumologie de Langue Française (SPLF) sur Asthme et Allergie".
    MeSH term(s) Asthma ; Consensus Development Conferences as Topic ; Humans ; Hypersensitivity
    Language French
    Publishing date 2006-12-15
    Publishing country France
    Document type Journal Article
    ZDB-ID 605743-3
    ISSN 0761-8425 ; 0301-0279
    ISSN 0761-8425 ; 0301-0279
    DOI 10.1016/s0761-8425(07)91044-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top